Loading Video…
This browser does not support the Video element.
FDA delays blood plasma as COVID-19 treatment
A study showed the treatment is promising, but the FDA wants more information about blood plasma's effectiveness.
This browser does not support the Video element.
A study showed the treatment is promising, but the FDA wants more information about blood plasma's effectiveness.